Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

889-900 of 1008 results
Page 75 of 84
Key Publications January 26, 2012

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.

J Lipid Res 2011;52:2169-76

Cao G, Beyer TP, Zhang Y, Schmidt RJ, Chen YQ, Cockerham SL, Zimmerman KM, Karathanasis SK, Cannady EA, Fields T, Mantlo NB
Hypertension Lipids/Lipoproteins Metabolism: Animal Studies
Key Publications January 24, 2012

Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care.

J Hypertens 2011;29:2332-8

Muntner P, Joyce C, Levitan EB, Holt E, Shimbo D, Webber LS, Oparil S, Re R, Krousel-Wood M
Hypertension
Key Publications January 24, 2012

The impact of birth weight on blood pressure and arterial stiffness in later life: the Enigma Study.

J Hypertens 2011;29:2324-31

Miles KL, McDonnell BJ, Maki-Petaja KM, Yasmin, Cockcroft JR, Wilkinson IB, McEniery CM, Enigma Study investigators
Hypertension Metabolism
Key Publications January 16, 2012

Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.

J Clin Endocrinol Metab 2011;96:3242-9

Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, Coviello AD, Florez JC, Fox CS, Levy D, Robins SJ, Arora P, Bhasin S, Lam CS, Vasan RS, Melander O, Wang TJ
Hypertension Insulin Resistance Obesity
Key Publications January 12, 2012

Titration of antihypertensive agents after their initiation: an important clinical issue now addressed.

Heart 2011;97:1721-2

Jiang JY, Wong MC
Hypertension
Key Publications January 12, 2012

How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.

Heart 2011;97:1771-5

Lasserson DS, Buclin T, Glasziou P
Hypertension
Key Publications January 10, 2012

Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference.

Am J Hypertens 2011;24:1245-9

Pierdomenico SD, Pierdomenico AM, Neri M, Cuccurullo F
Ectopic Fat Hypertension Metabolic Syndrome
Key Publications January 10, 2012

Thicker epicardial adipose tissue in nonobese hypertensive patients: an innocent bystander or overlooked villain?

Am J Hypertens 2011;24:1191-2

Wang TD, Chen MF
Ectopic Fat Hypertension Metabolic Syndrome
Key Publications January 10, 2012

Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study.

Am J Hypertens 2011;24:1250-6

Kawano Y, Ogihara T, Saruta T, Goto Y, Ishii M
Hypertension Metabolic Syndrome
Key Publications January 9, 2012

The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK.

Eur Heart J 2011;32:2525-32

Sever PS, Chang CL, Gupta AK, Whitehouse A, Poulter NR, on behalf of the ASCOT Investigators
Hypertension Lipids/Lipoproteins
Key Publications January 2, 2012

Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Circulation 2011;124:1811-8

Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR, for the ALLHAT Collaborative Research Group
Hypertension
Key Publications January 2, 2012

Hypertension and heart failure: the ALLHAT imperative.

Circulation 2011;124:1803-5

Rodeheffer RJ
Hypertension
of 84